Event Detail

WIB-Philadelphia Metro: "Childhood ADHD: The Past, Present, and Innovative Future," June 27, 2017

27
June
2017
Tuesday
From 6:00 PM TO 8:00 PM
Status:
Closed

Come along with us on a journey to explore the evolution of childhood attention-deficit/hyperactivity disorder (ADHD). Dr. Nicole Myer and Dr. Sari Goldman will discuss past trends, how the disease is currently treated and managed, and how scientific advances in the field of genetics will soon change the current state of treatment. Dr. Betsy Bove will be leading Genomind Laboratory tours throughout the event. Refreshments and appetizers will be served.

Speaker Biographies

Dr. Goldman has been helping children, adolescents, and adults for seven years. She received her Bachelor of Arts from Oberlin College and a Masters of Social Work from the University of Michigan. She is currently licensed as a social worker. She obtained her Doctorate in Clinical Psychology from Chestnut Hill College in Philadelphia. She creatively counsels individuals, couples, and families utilizing psychodynamic, strategic family therapy, child play therapy, and cognitive-behavioral techniques. She also administers and interprets comprehensive psychological testing for children and adults.

Dr. Nicole Myer received her PhD in Cellular and Molecular Biology from the University of the Sciences in Philadelphia. She has studied cellular components of angiogenic disease states to better understand blood vessel development and the regulation of virulence genes in microbial pathogens. Currently the Director of Clinical Research and Development at Genomind, she is executing the design and development of a novel childhood ADHD decision-support tool. She has authored/co-authored seven peer-reviewed publications and currently serves as a volunteer programming committee member for Women in Biology.

Dr. Betsy Bove has a background in genetics, molecular pathology, and molecular oncology. Receiving her PhD in Genetics and Molecular Biology from the University of Delaware she has spent her career overseeing regulatory and technical affairs within the molecular testing arena. She has a specific expertise in compliance and regulatory preparation (CAP/CLIA) from her time as the founding manager/director designee of the Clinical Molecular testing program within the Department of Pathology at the Fox Chase Cancer Center. Today, as the Assistant Laboratory Director at Genomind, oversees clinical testing and laboratory regulation preparation and shares with the director in data analysis and reporting. She has found the challenges in molecular oncology and psychiatry to be overlapping.

Walk-Ins Accepted?
Yes*
* - Walk-ins will be accepted at the door until event capacity is reached.

Program

6:00 p.m. – 6:30 p.m.

Arrival and Networking

6:30 p.m. – 6:45 p.m.

Welcome and Introductions

6:45 p.m. – 7:15 p.m.

Presentation

7:15 p.m. – 8:00 p.m.

Networking and Tours

Pricing Information
Members: $25
Non-Members: $45

Event Date/Time
Tuesday, June 27, 2017
6:00 p.m. – 8:00 p.m. EST

Parking Information
Free parking available in the lot located in front of the building

Public Transit Information
Take Septa bus and rail lines to King of Prussia

Maximum Capacity
100

Venue
Triad Atrium, 2200 Renaissance Boulevard King of Prussia, PA, 19406